Outcome Evaluation After Fertility Preservation

Cancer Clinical Trial

Official title:

Outcome Evaluation After Fertility Preservation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06043609
• Other study ID #: 2023.346
• Status: Recruiting
• Start date: September 21, 2023
• Est. completion date: October 1, 2035

Study information

• Verified date: September 2023
• Source: Chinese University of Hong Kong
• Contact: Jacqueline CHUNG, MBBS
• Phone: 35051537
• Email: jacquelinechung[@]cuhk.edu.hk
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

It is important to evaluate outcomes after different fertility preservation strategies. Therefore, this study aims to assess the outcomes after different fertility preservation strategies and identify any factors that may affect their reproductive outcome.

Description:

All patients who have undergone or will seek fertility preservation services in PWH will be invited to participate. For those patients who have undergone fertility preservation services in PWH, when they come back to use their frozen gametes or embryos, they will also be invited to participate. Medical record assessment When patients come for fertility preservation consultation in PWH, they will be invited to participate. The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background, past medical history, details of the surgical procedures, and the subsequent reproductive outcome, will be obtained by reviewing their hospital record. The participants will not be required to take any extra procedures.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: October 1, 2035
• Est. primary completion date: October 1, 2033
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 60 Years

Eligibility

Inclusion Criteria:

• Patients aged from 0-50 years old
• Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
• Patients seek for fertility preservation services Exclusion Criteria: -Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)

Related Conditions & MeSH terms

• Cancer
• Fertility Issues
• Infertility

Intervention

Other:
• This is an observational cohort study
This is an observational cohort study

Locations

Country	Name	City	State
Hong Kong	Prince of Wales Hospital	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To determine any factors that may affect the success rate of different fertility preservation methods.	The medical notes of these patients undergoing fertility preservation services will be reviewed. The baseline characteristics including the socio-demographic background will be obtained by reviewing their hospital record.	10 years
Secondary	To assess the pregnancy rate after different fertility preservation methods.	The medical notes of these patients undergoing fertility preservation services will be reviewed. The subsequent reproductive outcome will be obtained by reviewing their hospital record.	10 years
Secondary	To report on the frequency of surgical complications	The medical notes of these patients undergoing fertility preservation services will be reviewed. The details of the surgical procedures will be obtained by reviewing their hospital record.	10 years